
Veeva Systems VEEV
$ 178.11
-0.56%
Annual report 2026
added 03-20-2026
Veeva Systems Operating Cash Flow 2011-2026 | VEEV
Annual Operating Cash Flow Veeva Systems
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.42 B | 1.09 B | 911 M | 780 M | 764 M | 551 M | 437 M | 311 M | 233 M | 144 M | - | - | 41.8 M | 30.8 M | 4.74 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.42 B | 4.74 M | 517 M |
Quarterly Operating Cash Flow Veeva Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 877 M | - | - | 764 M | 82.6 M | 265 M | 506 M | - | 143 M | 93.4 M | 481 M | - | 113 M | 119 M | 478 M | - | 95.4 M | 105 M | 282 M | - | 61.5 M | 100 M | 236 M | - | 41.6 M | 86.8 M | 151 M | - | 32.2 M | 57.6 M | 142 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.27 M | - | - | - | 9.72 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 877 M | 5.27 M | 213 M |
Operating Cash Flow of other stocks in the Health information services industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-25.2 M | - | 0.29 % | $ 206 M | ||
|
Phreesia
PHR
|
-32.4 M | $ 11.28 | - | $ 615 M | ||
|
Change Healthcare
CHNG
|
697 M | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
1.77 B | - | - | $ 27.9 B | ||
|
American Well Corporation
AMWL
|
-66 M | $ 5.63 | -2.26 % | $ 90.3 M | ||
|
Computer Programs and Systems
CPSI
|
1.06 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
102 M | - | - | $ 2.94 B | ||
|
Schrödinger
SDGR
|
13.9 M | $ 11.4 | -1.47 % | $ 837 M | ||
|
iCAD
ICAD
|
-3.94 M | - | - | $ 102 M | ||
|
Teladoc Health
TDOC
|
294 M | $ 5.57 | 2.77 % | $ 982 M | ||
|
NextGen Healthcare
NXGN
|
98.5 M | - | - | $ 1.6 B | ||
|
1Life Healthcare
ONEM
|
-88.6 M | - | - | $ 3.37 B | ||
|
Premier
PINC
|
401 M | - | - | $ 2.33 B | ||
|
Omnicell
OMCL
|
188 M | $ 34.94 | 1.39 % | $ 1.61 B | ||
|
OptimizeRx Corporation
OPRX
|
-7.24 M | $ 7.18 | 5.9 % | $ 123 M | ||
|
Evolent Health
EVH
|
-11.6 M | $ 2.27 | 0.89 % | $ 213 M | ||
|
MTBC
MTBC
|
28.6 M | - | -0.58 % | $ 51.7 M | ||
|
GoodRx Holdings
GDRX
|
184 M | $ 2.06 | 0.98 % | $ 795 M | ||
|
SCWorx Corp.
WORX
|
-1.08 M | $ 0.13 | 1.5 % | $ 190 K | ||
|
Signify Health
SGFY
|
41.7 M | - | -0.02 % | $ 7.21 B | ||
|
R1 RCM
RCM
|
265 M | - | - | $ 3.81 B | ||
|
Akerna Corp.
KERN
|
-3.4 M | - | - | $ 161 M | ||
|
Zhongchao
ZCMD
|
-1.47 M | $ 1.8 | -0.55 % | $ 9.37 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
-75.4 M | - | -10.39 % | $ 886 M | ||
|
Health Catalyst
HCAT
|
731 K | $ 1.1 | 0.46 % | $ 76.9 M | ||
|
NantHealth
NH
|
-32.3 M | - | -46.64 % | $ 10.4 M | ||
|
HealthEquity
HQY
|
457 M | $ 82.47 | 0.45 % | $ 7.1 B | ||
|
HealthStream
HSTM
|
57.7 M | $ 21.23 | 1.24 % | $ 645 M | ||
|
10x Genomics
TXG
|
-15.2 M | $ 20.91 | 5.55 % | $ 2.45 B | ||
|
Streamline Health Solutions
STRM
|
-1.51 M | - | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
7.36 M | - | - | $ 255 M | ||
|
Progyny
PGNY
|
179 M | $ 17.75 | -1.66 % | $ 1.52 B | ||
|
So-Young International
SY
|
-25.6 M | $ 3.19 | 9.62 % | $ 253 M |